Half-year report · HY
4884.TEDINET S100Y2Q5
Period2025-10-01 → 2026-03-31
Filed2026-05-11
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥37m | 2025-10-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥72m | 2024-10-01 → 2025-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥36m | 2024-10-01 → 2025-03-31 | Standalone | Net sales |
| Operating income | −¥515m | 2025-10-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | −¥512m | 2024-10-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥514m | 2025-10-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥915m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥512m | 2024-10-01 → 2025-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥516m | 2025-10-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥512m | 2024-10-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥517m | 2025-10-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥916m | 2024-10-01 → 2025-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥512m | 2024-10-01 → 2025-03-31 | Standalone | Profit loss |
| Total assets | ¥2.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥2.1bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥2.3bn | at 2025-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.0bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥770m | at 2025-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥948m | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2025-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥960m | at 2026-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥991m | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2024-09-30v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥169m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥756m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥405m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥2m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥154m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥155m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥141m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥84m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-71.37 | 2025-10-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-133.92 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-75.15 | 2024-10-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 45.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.2% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 7,395,200 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,018,200 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,837,200 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 349
| Item | Context | Value | Unit |
|---|---|---|---|
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 村上 浩一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市北区中之島4-3-51Nakanoshima Qross 未来医療R&Dセンター10階 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)06-7653-6728（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 村上 浩一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E36129 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48840 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)クリングルファーマ株式会社 | |
| Filer name in english | FilingDateInstant | Kringle Pharma, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2025-10-01 | |
| Current period end date | FilingDateInstant | 2026-03-31 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2024-10-01 | |
| Comparative period end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2025-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)日本全薬工業株式会社 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)福島県郡山市安積町笹川字平ノ上１－１ | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)STATE STREET BANK AND TRUST COMPANY（常任代理人 株式会社みずほ銀行決済営業部） | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |